DIPYRIDAMOLE KINETICS

[1] CONTROLLED TRIAL OF DIPYRIDAMOLE IN CEREBRAL VASCULAR DISEASE [J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 1 (5644): : 614 - +

[2] BEISENHERZ G, 1960, ARZNEIMITTEL-FORSCH, V10, P307

[3] BJORNSSON TD, 1979, CLIN PHARMACOL THER, V26, P540

[4] POTENTIAL SOURCE OF ERROR IN ABSORPTION RATE CALCULATIONS [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1975, 3 (04): : 257 - 264

[5] BROWSE NL, 1969, LANCET, V2, P718

[6] CUCUIANU MP, 1971, J LAB CLIN MED, V77, P958

[7] ELFRING GL, 1978, 125TH ANN M APHA AC

[8] SOME CONSIDERATIONS AS TO DETERMINATION AND SIGNIFICANCE OF BIOLOGIC HALF-LIFE [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (04) : 624 - +

[9] GIBALDI M, 1975, PHARMACOKINETICS, P80

[10] PLATELET AND FIBRINOGEN CONSUMPTION IN MAN [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (20) : 999 - &

[1] CONTROLLED TRIAL OF DIPYRIDAMOLE IN CEREBRAL VASCULAR DISEASE [J]. BMJ-BRITISH MEDICAL JOURNAL, 1969, 1 (5644): : 614 - +

[2] BEISENHERZ G, 1960, ARZNEIMITTEL-FORSCH, V10, P307

[3] BJORNSSON TD, 1979, CLIN PHARMACOL THER, V26, P540

[4] POTENTIAL SOURCE OF ERROR IN ABSORPTION RATE CALCULATIONS [J]. JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1975, 3 (04): : 257 - 264

[5] BROWSE NL, 1969, LANCET, V2, P718

[6] CUCUIANU MP, 1971, J LAB CLIN MED, V77, P958

[7] ELFRING GL, 1978, 125TH ANN M APHA AC

[8] SOME CONSIDERATIONS AS TO DETERMINATION AND SIGNIFICANCE OF BIOLOGIC HALF-LIFE [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (04) : 624 - +

[9] GIBALDI M, 1975, PHARMACOKINETICS, P80

[10] PLATELET AND FIBRINOGEN CONSUMPTION IN MAN [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1972, 287 (20) : 999 - &